On June 30, QingSong Health (02661.HK) declined 8.02% in regular trading, trading at HKD 12.16/share, with turnover of HKD 20.28 million. The stock price has sharply broken below the company's June 29 buyback price range of HKD 13.47–14.51.

Despite multiple supportive measures — including a HKD 100 million share buyback plan announced on June 22, controlling shareholder Yang Yin's voluntary lock-up extension to January 1, 2027, and an actual repurchase of 700,000 shares for approximately HKD 9.95 million on June 29 — market selling pressure remains unrelieved. The key overhang is the expiry of the 6-month post-IPO lock-up period around June 30, with approximately 43 million shares from cornerstone investors and controlling shareholders becoming eligible for sale, representing over 20% of total equity.

Within the Health Care Services sector, the overall sector weakened. Among individual stocks, HEALTHYWAY INC down 3.78%, JXR down 2.99%, UNI MEDICAL down 1.12%, SOFTMEDX-NEW down 0.81%, GUSHENGTANG up 0.15%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)